ロード中...

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

INTRODUCTION: Tumor necrosis factor (TNF) antagonists reduce the signs and symptoms of spondyloarthritides, including ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Our objective was to evaluate the effectiveness and safety of adalimumab, 40 mg every other week, for patients with AS or P...

詳細記述

保存先:
書誌詳細
主要な著者: Rudwaleit, Martin, Van den Bosch, Filip, Kron, Martina, Kary, Sonja, Kupper, Hartmut
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2911911/
https://ncbi.nlm.nih.gov/pubmed/20553600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3054
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!